SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Quantitative Assessment of Visible Nigrosome-1 in Patients with Parkinson's Disease.

Mov Disord Clin Pract · 2026-02-03

DOI: 10.1002/mdc3.70547PMID: 41631667

Open accessbrief-report; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

BackgroundThe nigrosome-1 (N1) sign on susceptibility-weighted imaging (SWI) typically disappears in Parkinson's disease (PD), though some patients can show uni-/bilaterally preserved N1.ObjectiveInvestigating whether visible nigrosomes in PD patients differ from those of healthy subjects (HC).MethodsForty-eight PD and 35 HC underwent 3 T-MR-SWI. The N1 was visually assessed, and visible N1 were segmented to calculate volume, area and susceptibility values. These metrics were investigated for distinguishing between visible nigrosomes-1 of PD patients and HC.ResultsAmong PD patients, 16 had bilateral N1 loss and 32 had unilaterally (n = 27) or bilaterally (n = 5) preserved N1. The visible N1 were significantly smaller in PD than in HC (P ConclusionThe measurement of volume and area of N1 region may complement visual assessment on SWI to optimize diagnostic performance in PD.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.